Home › NDC Lookup › RxCUI directory › RxCUI 2630753

Cefazolin 3000 MG Injection — RxCUI 2630753

Name: Cefazolin 3000 MG Injection (RxCUI 2630753)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 2630753 Semantic clinical drug · SCD ● Current RxNorm concept 13 FDA products 13 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2630753

Official nameCefazolin 3000 MG Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known ascefazolin (as cefazolin sodium) 3 GM Injection; ceFAZolin 3 GM Injection

FDA products mapped13

Package NDCs mapped13

Reported Medicaid activity (SDUD)119,093 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Cefazolin Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

It is an antibiotic for bacterial infections of the lungs, urinary tract, skin, bile ducts, bones and joints, genital tract, blood and heart valves. It is also used to help prevent...
A healthcare professional gives it, usually into a vein over about 30 minutes, though some products can be given into a muscle. It is repeated several times a day for infections. B...
The more common ones are nausea, vomiting, diarrhea, rash, headache and soreness at the injection site. These are usually mild. Tell your nurse if something bothers you.
Get emergency help for trouble breathing, swelling, hives or chest pain. Also tell your team about seizures, severe or watery diarrhea (even weeks later), unusual bleeding, or blis...

📖 Read our full Cefazolin Injection guide →

🕸️ Concept Web — How Cefazolin 3000 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Cefazolin 3000 MG Injection RxCUI 2630753 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Cefazolin 2180 IN
Dose forms 4

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Cefazolin Injection 1665049 SCDF
- Cefazolin Injectable Product 1152094 SCDG
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 1

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Cefazolin 3000 MG 2630752 SCDC

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Cefazolin 3000 MG SCDC · 2630752
Cefazolin Injection SCDF · 1665049
Cefazolin Injectable Product SCDG · 1152094

📦 FDA Products & Package NDCs

13 products · 13 package NDCs

13 package NDCs map to RxCUI 2630753 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00143-9139-25	25 VIAL in 1 CARTON (0143-9139-25) / 1 INJECTION, POWDER, F...	Cefazolin	Hikma Pharmaceuticals USA Inc.	2023-03-01
00143-9140-25	25 VIAL in 1 CARTON (0143-9140-25) / 1 INJECTION, POWDER, F...	Cefazolin	Hikma Pharmaceuticals USA Inc.	2023-03-01
00264-3103-11	24 CONTAINER in 1 CASE (0264-3103-11) / 50 mL in 1 CONTAINE...	Cefazolin Sodium	B. Braun Medical Inc.	2000-07-27
00264-3105-11	24 CONTAINER in 1 CASE (0264-3105-11) / 50 mL in 1 CONTAINE...	Cefazolin Sodium	B. Braun Medical Inc.	2012-01-13
00264-3107-11	24 CONTAINER in 1 CASE (0264-3107-11) / 50 mL in 1 CONTAINE...	Cefazolin Sodium	B. Braun Medical Inc.	2025-03-10
00338-0096-06	6 BAG in 1 CARTON (0338-0096-06) / 150 mL in 1 BAG	Cefazolin	Baxter Healthcare Corporation	2024-05-31
00338-3503-41	24 BAG in 1 CARTON (0338-3503-41) / 50 mL in 1 BAG	Cefazolin	Baxter Healthcare Corporation	2015-08-07
00338-3508-41	12 BAG in 1 CARTON (0338-3508-41) / 100 mL in 1 BAG	Cefazolin	Baxter Healthcare Corporation	2015-08-07
44567-0840-25	25 VIAL in 1 CARTON (44567-840-25) / 1 INJECTION, POWDER, F...	Cefazolin	WG Critical Care, LLC	2023-05-18
44567-0845-25	25 VIAL in 1 CARTON (44567-845-25) / 1 INJECTION, POWDER, F...	Cefazolin	WG Critical Care, LLC	2024-05-10
60505-6142-05	25 VIAL, SINGLE-DOSE in 1 CARTON (60505-6142-5) / 1 INJECTI...	Cefazolin	Apotex Corp.	2017-06-30
60505-6231-05	25 VIAL, SINGLE-DOSE in 1 CARTON (60505-6231-5) / 1 INJECTI...	Cefazolin	Apotex Corp.	2022-03-18
60505-6266-05	25 VIAL, SINGLE-DOSE in 1 CARTON (60505-6266-5) / 1 INJECTI...	Cefazolin	Apotex Corp.	2024-02-13

Observed labelers: Apotex Corp. (3) · B. Braun Medical Inc. (3) · Baxter Healthcare Corporation (3) · Hikma Pharmaceuticals USA Inc. (2) · WG Critical Care, LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J0690	Cefazolin sodium injection	6	CMS
J0689	Inj cefazolin sodium, baxter	3	CMS
J0687	Inj cefazolin (wg crit care)	2	CMS
J0688	Inj cefazolin sodium, hikma	2	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.